Intravenous immunoglobulin utilization in a tertiary care teaching hospital in Saudi Arabia

Saudi Medical Journal

Volumn 29, Issue 7, 2008, Pages 975-979

  Alangari, Abdullah A ^a   Abutaleb, Mohammad H ^a   Albarraq, Ahmad A ^b   Al Dhowailie, Abdullatif A ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN;

ADULT; ARTICLE; CHILD; CONTROLLED STUDY; DATA COLLECTION METHOD; DEMOGRAPHY; DOSE RESPONSE; DRUG COST; DRUG EFFICACY; DRUG INDICATION; DRUG UTILIZATION; FEMALE; FOOD AND DRUG ADMINISTRATION; HOSPITAL MANAGEMENT; HUMAN; IMMUNE DEFICIENCY; INFANT; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MEDICATION ERROR; OFF LABEL DRUG USE; PATIENT IDENTIFICATION; PRESCRIPTIVE AUTHORITY; SAUDI ARABIA; TEACHING HOSPITAL; TERTIARY HEALTH CARE; TREATMENT DURATION;

ADULT; CHILD; DRUG COSTS; DRUG UTILIZATION; FEMALE; HOSPITALS, TEACHING; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; MALE; PHYSICIAN'S PRACTICE PATTERNS; RETROSPECTIVE STUDIES; SAUDI ARABIA;

EID: 57349189350     PISSN: 03795284     EISSN: 16583175     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Jolles S, Sewell WAC, Misbah SA. Clinical uses of intravenous immunoglobulin. Clin Exp Immunol 2005; 142: 1-11.
2. Pierce LR, Jain N. Risks associated with the use of intravenous immunoglobulin. Transfus Med Rev 2003; 17: 241-251.
3. Lernieux R, Bazin R, Neron S. Theraputic intravenous immunoglobulins. Mat Immunol 2004;42:839-48.
4. Knezevic-Maramica I, Kruskall MS. Intravenous immune globulins: An update for clinicians. Transfusion 2003; 43: 1460-1480.
5. Chen C, Danekas LH, Ratko TA, Vlasses PH, Matuszewski KA. A multicenter drug use surveillance of intravenous immunoglobulin utilization in US academic health centers. Ann Pharmacother 2000; 34: 295-299.
6. Ratko TA, Burnett DA, Foulke GF, Matuszewski KA, A. SR. Recommendations for off-label use of intravenously administered immunoglobulin preparations. JAMA 1995; 273: 1865-1870.
7. Darabi K, Abdel-Wahab O, Dzik WH. Current usage of intravenous immunoglobulin and the rationale behind it: The Mamchusetts General Hospital data and a review of the literature. Transfusion 2006; 46: 741-753.
8. Orange JS, Hossny EM, Weiler CR, Ballow M, Berger M, Bonilla FA, et al. Use of intravenous immunoglobulin in human disease: A review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and Immunology. J Allergy Clin Immunol 2006; 117: S525-S553.
9. Kumar A, Teuber SS, Gershwin M, E. Intravenous immunoglobulin: Striving for appropriate use. Int Arch Allergy Immunol 2006; 140: 185-198.
10. Lee YC, Woodfield DG, Douglas R. Clinicalusage of intravenous immunoglobulins in Auckland. N Z Med J 1998; 110: 48-50.
11. Badia MP, Cardona LP, Massanes RJ. Changes in the pattern of intravenous immunoglubulin use over a 5-year period. The European Journal of Hospital Pharmacy Science 2006; 12: 67-71.
12. Gajewski LK, Bailey EM, Brown PD, Chandrasekar PH. Immune globulin use at a multihospital medical center. Am J Hosp Pharm 1994; 51: 801-805.
13. Hanna K, Poulin-Costello M, Preston M, Maresky N. Intravenous immune globulin use in Canada. Can J Clin Pharmacol 2003; 10: 11-16.
14. Pendergrast JM, Sher GD, Callum JL. Changes in intravenous immunoglobulin prescribing patterns during a period of severe product shortages, 1995-2000. Vex Seug 2005; 89: 150-160.
15. Constantine MM, Thomas W, Whitman L, Kahwash E, Dolan S, Smith S, et al. Intravenous immunoglobulin utilization in the Canadian Atlantic provinces: A report of the Atlantic Collaborative Intravenous Immune Globulin Utilization Working Group. Transfusion 2007; 47: 2072-2080.
16. Frayha HH, Nuessle SJ, Arishi H, Rayes H, Qunibi WY, Bazarbashi MS. Improving utilization of intravenous immune globulin through concurrent use of an indication form. Eur J Clin Pharmacol 1997; 52: 255-260.